跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pulmodual MDI - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pulmodual MDI
Approved
STANDARD
Pulmodual MDI
Midas-Care Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8dc4c06cec5d39aa
Company
Midas-Care Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
8dc4c06cec5d39aa
Drug Approval Philippines Name
Pulmodual MDI
Product Name
Pulmodual MDI
Registration Number
DRP-4809
Brand Name
Pulmodual MDI
Generic Name
Salbutamol (As Sulfate) + Ipratropium Bromide
Dosage Form
Metered Dose Inhaler
Dosage Strength
100mcg/20mcg Per Actuation
Manufacturer
Midas-Care Pharmaceuticals Pvt. Ltd.
Importer
MedEthix, Inc.
Distributor
The Cathay Drug Co., Inc.
Issuance Date
28 June 2022
Expiry Date
28 June 2027
Pharmacologic Category
Bronchodilator
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8dc4c06cec5d39aa
Type
Standard
Back to Philippines FDA Approvals